共 22 条
- [1] Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients[J]. Feng Xia,Li-Li Wu,Wan-Yee Lau,Hong-Bo Huan,Xu-Dong Wen,Kuan-Sheng Ma,Xiao-Wu Li,Ping Bie.World Journal of Gastroenterology. 2016(23)
- [2] Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma[J]. Jiang Li,Yu Hou,Xiao-Bei Cai,Bin Liu.World Journal of Gastroenterology. 2016(15)
- [3] Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma[J]. Zhong-Xia Wang,Chun-Ping Jiang,Yin Cao,Guang Zhang,Wei-Bo Chen,Yi-Tao Ding.Hepatobiliary & Pancreatic Diseases International. 2015(02)
- [4] Risk factors for early recurrence of small hepatocellular carcinoma after curative resection[J]. Yan-Ming Zhou,Jia-Mei Yang,Bin Li,Zheng-Feng Yin,Feng Xu,Bin Wang,Wen Xu and Tong Kan Department of Hepato-Biliary-Pancreato-Vascular Surgery,First Xiamen Hospital,Fujian Medical University,Xiamen 361003,China;Department of Special Treatment,Department of Molecular Oncology,Department of Pathology,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai 200438,China.Hepatobi
- [6] Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial[J] . Jordi Bruix,Tadatoshi Takayama,Vincenzo Mazzaferro,Gar-Yang Chau,Jiamei Yang,Masatoshi Kudo,Jianqiang Cai,Ronnie T Poon,Kwang-Hyub Han,Won Young Tak,Han Chu Lee,Tianqiang Song,Sasan Roayaie,Luigi Bolondi,Kwan Sik Lee,Masatoshi Makuuchi,Fabricio Souza,Marie-Aude Le Berre,Gerold Meinhardt,Josep M Llovet.The Lancet Oncology . 2015 (13)
- [9] Liver resection for hepatocellular carcinoma in patients without cirrhosis[J] . A. Thelen,C. Benckert,H.‐M. Tautenhahn,H.‐M. Hau,M. Bartels,J. Linnemann,J. Bertolini,M. Moche,C. Wittekind,S. Jonas.Br J Surg . 2012 (1)